These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Increased energy expenditure in cystic fibrosis is associated with specific mutations. O'Rawe A; McIntosh I; Dodge JA; Brock DJ; Redmond AO; Ward R; Macpherson AJ Clin Sci (Lond); 1992 Jan; 82(1):71-6. PubMed ID: 1310920 [TBL] [Abstract][Full Text] [Related]
12. Neonatal screening strategy for cystic fibrosis using immunoreactive trypsinogen and direct gene analysis. Ranieri E; Ryall RG; Morris CP; Nelson PV; Carey WF; Pollard AC; Robertson EF BMJ; 1991 May; 302(6787):1237-40. PubMed ID: 2043846 [TBL] [Abstract][Full Text] [Related]
13. Neonatal screening for the cystic fibrosis main mutation delta F508 in Estonia. Klaassen T; Teder M; Viikmaa M; Metspalu A J Med Screen; 1998; 5(1):16-9. PubMed ID: 9575453 [TBL] [Abstract][Full Text] [Related]
14. Screening for cystic fibrosis in newborn infants: results of a pilot programme based on a two tier protocol (IRT/DNA/IRT) in the Italian population. Corbetta C; Seia M; Bassotti A; Ambrosioni A; Giunta A; Padoan R J Med Screen; 2002; 9(2):60-3. PubMed ID: 12133923 [TBL] [Abstract][Full Text] [Related]
15. [Correlation between phenotype and genotype in a group of patients with cystic fibrosis]. Navarro H; Kolbach M; Repetto G; Guiraldes E; Harris P; Foradori A; Poggi H; Sánchez I Rev Med Chil; 2002 May; 130(5):475-81. PubMed ID: 12143267 [TBL] [Abstract][Full Text] [Related]
16. Resting energy expenditure, pulmonary inflammation, and genotype in the early course of cystic fibrosis. Thomson MA; Wilmott RW; Wainwright C; Masters B; Francis PJ; Shepherd RW J Pediatr; 1996 Sep; 129(3):367-73. PubMed ID: 8804325 [TBL] [Abstract][Full Text] [Related]
17. Cystic fibrosis: the delta F508 mutation does not lead to an exceptionally severe phenotype. A cohort study. Borgo G; Gasparini P; Bonizzato A; Cabrini G; Mastella G; Pignatti PF Eur J Pediatr; 1993 Dec; 152(12):1006-11. PubMed ID: 8131801 [TBL] [Abstract][Full Text] [Related]
18. [Screening of newborn infants for cystic fibrosis. A combined analysis of immunoreactive trypsin and delta F508 mutation--a screening without false positive results]. Nørgaard-Pedersen B; Høgdall EV; Arends J; Vuust J Ugeskr Laeger; 1994 Jun; 156(25):3757-60. PubMed ID: 8059453 [TBL] [Abstract][Full Text] [Related]
19. Neonatal screening for cystic fibrosis in the Trent region (UK): two-stage immunoreactive trypsin screening compared with a three-stage protocol with DNA analysis as an intermediate step. Pollitt RJ; Dalton A; Evans S; Hughes HN; Curtis D J Med Screen; 1997; 4(1):23-8. PubMed ID: 9200059 [TBL] [Abstract][Full Text] [Related]
20. The relation between genotype and phenotype in cystic fibrosis--analysis of the most common mutation (delta F508). Kerem E; Corey M; Kerem BS; Rommens J; Markiewicz D; Levison H; Tsui LC; Durie P N Engl J Med; 1990 Nov; 323(22):1517-22. PubMed ID: 2233932 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]